Therapeutic Targets – Modulation, Inhibition and Activation
Autor LM Botanaen Limba Engleză Hardback – 7 iun 2012
Preț: 814.65 lei
Preț vechi: 1200.35 lei
-32% Nou
Puncte Express: 1222
Preț estimativ în valută:
155.89€ • 164.62$ • 129.73£
155.89€ • 164.62$ • 129.73£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780470587195
ISBN-10: 0470587199
Pagini: 494
Dimensiuni: 164 x 237 x 31 mm
Greutate: 0.84 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470587199
Pagini: 494
Dimensiuni: 164 x 237 x 31 mm
Greutate: 0.84 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Pharmacologists, biochemists, medicinal chemists, pharmaceutical and biomedical researchers.Cuprins
Notă biografică
Luis M. Botana was Director of the Department of Pharmacology at the University of Santiago de Compostela (USC), Director of the European Union Reference Laboratory for Marine Biotoxins, and scientific advisor to the drug company LCIFGA. The author of 200 papers and 15 patents, Dr. Botana is the editor of several other books, including Phycotoxins: Chemistry and Biochemistry, published by Wiley (2007). Mabel Loza is Professor of Pharmacology at the University of Santiago de Compostela (USC). She created the USEF Drug Screening Platform, with more than ten years of experience in public and private mixed early drug discovery programs.
Descriere
Providing insight into where the next generations of drugs are likely to emerge, this book describes the pharmacology of therapeutically undefined targets and potential applications. In some cases, there are no defined drugs to modulate some of the targets, and in other cases inhibition or activation will render different therapeutic uses.